Dose Finding Study in COPD
Public ClinicalTrials.gov record NCT00122434. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multiple-dose, Double-blind, Placebo- and Active-controlled, Parallel Group Efficacy and Safety Study to Determine the Optimum Dose of BEA 2180 BR Delivered by the Respimat® Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to determine the optimum dose of BEA 2180 BR inhalation solut ion delivered by the Respimat ? inhaler once daily for four weeks in patients with COPD.
Study identification
- NCT ID
- NCT00122434
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 389 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 83 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2005 (Type not available)
- Primary completion
- May 2006 (Actual)
- Completion
- Not listed
- Last update posted
- Dec 28, 2017
Started 2005
United States locations
- U.S. sites
- 27
- U.S. states
- 16
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Lung Health Center | Birmingham | Alabama | — | — |
| Vapahcs 111P | Palo Alto | California | — | — |
| Boehringer Ingelheim Investigational Site | San Diego | California | — | — |
| GLAHS Sepulveda | Sepulveda | California | — | — |
| Rehabilitation Clinical Trial Center | Torrance | California | — | — |
| Boehringer Ingelheim Investigational Site | Wheat Ridge | Colorado | — | — |
| Hospital for Special Care | New Britain | Connecticut | — | — |
| Bay Pines VA Medical Center | Bay Pines | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Panama City | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Pembroke Pines | Florida | — | — |
| Boehringer Ingelheim Investigational Site | Coeur d'Alene | Idaho | — | — |
| LSUHSC - Shreveport | Shreveport | Louisiana | — | — |
| VAMC-Reno | Reno | Nevada | — | — |
| North Shore Universtiy Hospital | New Hyde Park | New York | — | — |
| SVMMC | Toledo | Ohio | — | — |
| Boehringer Ingelheim Investigational Site | Medford | Oregon | — | — |
| Hershey Medical Center | Hershey | Pennsylvania | — | — |
| Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | — | — |
| Frank Sciurba | Pittsburgh | Pennsylvania | — | — |
| Boehringer Ingelheim Investigational Site | Charleston | South Carolina | — | — |
| MUSC | Charleston | South Carolina | — | — |
| Boehringer Ingelheim Investigational Site | Spartanburg | South Carolina | — | — |
| Boehringer Ingelheim Investigational Site | Harker Heights | Texas | — | — |
| MEDVAMC | Houston | Texas | — | — |
| McGuire VA | Fredericksburg | Virginia | — | — |
| Boehringer Ingelheim Investigational Site | Richmond | Virginia | — | — |
| Boehringer Ingelheim Investigational Site | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00122434, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 28, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00122434 live on ClinicalTrials.gov.